Score Overview
Explore the 2021 public Archive ranking →
Where Fate Therapeutics Inc has ranked, year by year
Showing all available years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- FATE
2019: 98.2% · 2021: 93.9% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-30 | $ 2.37 | — |
1 Year2025-09-30 | $ 1.26 | 88.10% |
5 Years2021-09-30 | $ 59.27 | -96.00% |
10 Years2016-09-30 | $ 3.12 | -24.04% |
All Time2013-10-01 | $ 6.62 | -64.20% |
| Period | Last Price2026-09-30 | 1 Year2025-09-30 | 5 Years2021-09-30 | 10 Years2016-09-30 | All Time2013-10-01 |
|---|---|---|---|---|---|
| Price | $ 2.37 | $ 1.26 | $ 59.27 | $ 3.12 | $ 6.62 |
| Return | — | 88.10% | -96.00% | -24.04% | -64.20% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 6M | -$ 129M | $ 174M |
| 2025 | $ 6M | -$ 136M | $ 203M |
| 2024 | $ 13M | -$ 186M | $ 279M |
| 2023 | $ 63M | -$ 160M | $ 315M |
| 2022 | $ 96M | -$ 255M | $ 436M |
| 2021 | $ 55M | -$ 212M | $ 615M |
| 2020 | $ 31M | -$ 173M | $ 482M |
| 2019 | $ 10M | -$ 98M | $ 221M |
| 2018 | $ 4M | -$ 66M | $ 201M |
| 2017 | $ 4M | -$ 42M | $ 100M |
| 2016 | $ 4M | -$ 33M | $ 92M |
| 2015 | $ 2M | -$ 29M | $ 64M |
| 2014 | $ 0.00 | -$ 25M | $ 49M |
| IPO2013 | $ 971K | -$ 20M | $ 54M |
Fate Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 31M to $ 6M and net income went from -$ 173M to -$ 136M. Revenue increased in 1 of those 5 years; net income in 3.
Across Fate Therapeutics Inc's full reported history, from 2013 to 2025, revenue grew from $ 971K to $ 6M and net income went from -$ 20M to -$ 136M. Revenue increased in 54% of the years measured; net income in 23%.
Fate Therapeutics Inc currently holds a 5-year HDB Score of 4.1 out of 10. How the HDB Score is calculated.
Membership
Continue FATE’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
